Zynerba chief defends Zygel amid selloff; shares down 15% [Seeking Alpha]
Zynerba Pharmaceuticals, Inc. (ZYNE)
Last zynerba pharmaceuticals, inc. earnings: 3/10 06:50 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.zynerba.com
Company Research
Source: Seeking Alpha
Zynerba chief defends Zygel amid selloff; shares down 15% Zynerba Pharmaceuticals ( ZYNE -14.6% results 33% In a telephone interview, CEO Armando Anido countered that Zygel has a better safety profile than GW Pharmaceuticals' ( GWPH +0.2% package insert Topline results showed that treatment with Zygel reduced the most common and debilitating seizure types by 44 - 58% after two to six months. 48 patients were included in the safety assessment. The discontinuation rate was 16.7% (n=8/48), one for an application site reaction and seven for withdrawal of consent or perceived lack of efficacy. 96% (n=46/48) experienced a treatment-emergent adverse event (TEAE), most mild or moderate. The most common were application site dryness (8.3%), application site pain (8.3%) and drowsiness (8.3%). 20.8% (n=10/48) experienced a serious adverse event, most infection-related, with two possibly related to treatment.
Show less
Read more
Impact Snapshot
Event Time:
ZYNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYNE alerts
High impacting Zynerba Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics